[1]
Latorre Martinez, M. et al. 2015. The regulatory and Health Technology processes in Europe and drug market access. The case of cystic fibrosis. Farmeconomia. Health economics and therapeutic pathways. 16, 4 (Dec. 2015), 103–110. DOI:https://doi.org/10.7175/fe.v16i4.1207.